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Introduction
Aconitum carmichaeli Debx. and Aconitum kusnezoffii 
Reichb. (Ranunculaceae) have been widely used in the 
system of traditional Chinese medicine (TCM), primar-
ily for analgesic purposes. Radix aconiti (dried mother 
root tuber of A. carmichaeli Debx., Chinese name: 
Chuanwu) and its processed form (Zhichuanwu), Radix 
aconiti lateralis praeparata (processed daughter root 
of A. carmichaeli Debx., Chinese name: Fuzi), Radix 
aconiti kusnezoffii (dried root tuber of A. kusnezoffii 
Reichb., Chinese name: Caowu), and its processed form 
(Zhicaowu), and Folium aconiti kusnezoffii (Caowuye) 
are listed in the Pharmacopoeia of the People’s Republic 
of China (Chinese Pharmacopoeia Commission, 2005). 
Unprocessed aconite roots are very toxic due to the pres-
ence of diterpene–diester alkaloids (Xiao et al., 2006); 
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therefore, Radix aconiti and Radix aconiti kusnezoffii are 
allowed to be applied only after processing.
The main toxic compounds of A. kusnezoffii and A. 
carmichaelii are the aconitine-type diterpene alkaloids 
aconitine, mesaconitine, and hypaconitine (Figure 1). 
These compounds possess high affinity to the site II of 
Na+ channels, the ability to enhance [Na+]
i
 and [Ca2+]
i
, a 
strong arrhythmogenic action that starts at about 30 nM, 
and high acute toxicity (LD
50
 values about 0.15 mg/
kg) (Gutser et al., 1998). The main causes of death are 
refractory ventricular arrhythmias and asystole and 
the overall in-hospital mortality is 5.5%. In Asia, aco-
nite poisoning is much more common because of the 
continued use of aconite roots in traditional medicine. 
However, with easy access to Asian herbal medicines 
in western societies, aconite poisoning can occur any-
where in the world (Chan, 2009).
Processing reduces toxicity because of hydrolysis 
of the ester groups of aconitine-type alkaloids (Chan, 
2009). First, the acetyl group is hydrolyzed and in the 
second step the benzoyl group is hydrolyzed (Figure 2). 
Since the benzoyl ester is more stable, in the properly 
processed plant material the concentration of benzoy-
laconine, benzoylmesaconine, and benzoylhypaconine 
is remarkable. The LD
50
 values of aconitine in mice are 
1.80 mg/kg p.o., 0.31 mg/kg i.p., and 0.12 mg/kg i.v., of 
benzoylaconine 1500 mg/kg p.o., 70 mg/kg i.p., and 
23 mg/kg i.v., and of aconine 120 mg/kg i.v. (Wada et al., 
2006). Aconitum roots also contain the so-called lipo-
alkaloids, which are compounds esterified with fatty 
acids in the C-8 position. Lipo-alkaloids are more sta-
ble than aconitine-type alkaloids and can be detected 
both in unprocessed and in processed roots (Wang 
et al., 2002, 2003). Lipo-alkaloids are substantially less 
toxic than aconitine-type compounds as evidenced by 
the difference in the lethal intravenous single doses 
(>10 mg/kg for lipo-alkaloids) (Csupor et al., 2009). 
Due to insufficient control, several cases of poisoning 
have been reported (Singhuber et al., 2009), that may 
be the result of diverse alkaloid content of the starting 
material, unproper processing, and not least the lack of 
appropriate quality control.
Quality control criteria of pharmacopoeias are not 
always sufficient to warrant safety. In case of Radix aco-
niti and Radix aconiti kusnezoffii, the diterpene alkaloid 
content is not limited in the Chinese Pharmacopoeia and 
the warning of the Chinese Pharmacopoeia (“be cautious 
about the unprocessed root taken orally”) is not com-
mensurable to the danger of toxicity. In the Radix aco-
niti praeparata and Radix aconiti kusnezoffii praeparata 
monographs, a rather complicated colorimetric assay is 
used for the determination of diester alkaloids (required 
content level should not be >0.15%), and a titrimetric 
assay for the determination of the total alkaloid content 
(required level should not be <0.20% of alkaloids, calcu-
lated as aconitine). The dosage of these two herbal drugs 
is 1.5–3 g, which may contain as much as 4.5 mg diester-
type alkaloids (Chinese Pharmacopoeia Commission, 
2005). Moreover, for Radix aconiti lateralis praeparata, 
the dose of which is 3–15 g, only a quantitatively not too 
reliable TLC analysis of aconitine is specified (Chinese 
Pharmacopoeia Commission, 2005). Taking into account 
that the minimum lethal dose of aconitine is 3–6 mg 
(Caravati et al., 2004), it is obvious that only careful 
Figure 1. The main toxic Aconitum diterpene alkaloids.
Figure 2. Decomposition of aconitine during processing of Aconitum drugs.
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processing and quality control may warrant the safety of 
aconite containing medicinal products.
There are no Aconitum monographs neither in 
the U.S. Pharmacopoeia (USP) nor in the European 
Pharmacopoeia (Ph. Eur.). However, Aconitum napellus 
is included in the Swiss Pharmacopoeia (Pharmacopoeia 
Helvetica, 1988) and the monographs for Aconiti carmi-
chaeli radix, Aconiti radix praeparata, Aconiti radix later-
alis praeparata, Aconiti kusnezoffii radix praeparata, and 
Aconitum napellus and praeparationes homeopathicas 
are under preparation according to the on-line database 
of Ph. Eur (EDQM homepage). Since A. napellus has been 
applied in homeopathy, several homeopathic pharmaco-
poeias contain its monograph. However, the essence of 
these methods as demonstrated in the most prominent 
homeopathic pharmacopoeia, the German Homeopathic 
Pharmacopoeia (2005), is the titrimetric determina-
tion of total alkaloid content (German Homeopathic 
Pharmacopoeia, 2005).
Since the titrimetric determination provides no direct 
information on the toxic diester-type alkaloid content of 
aconite roots, more reliable methods are required for the 
quality control of processed plant material. The goal of our 
work was to develop a quick and simple HPLC method 
for the quality control of aconite roots with comparable 
or better reliability to those of the previously published 
methods (Jiang et al., 2005; Xie et al., 2005; Wang et al., 
2006; Kang et al., 2010), to compare the results of titration 
method with HPLC analysis of the toxic alkaloids, and to 
assess the reliability of these methods using an in vivo 
toxicity test.
Methods
The content of mesaconitine, aconitine, and hypaconi-
tine has been determined in 16 commercial samples of 
processed aconite roots by HPLC and alkaloid titration.
Processed Aconitum samples were obtained from dif-
ferent suppliers (see Table 1). Unprocessed A. carmichaelii 
roots (one sample) were obtained from a pharmacy in 
China. Aconitine, mesaconitine, and hypaconitine were 
purchased from PhytoLab GmbH, Vestenbergsgreuth, 
Germany.
Acetonitrile (Merck) was of HPLC grade. All other 
chemicals were purchased from Spektrum-3D Ltd., 
Hungary. HPLC analysis was carried on a Waters HPLC-
DAD system equipped with Waters 2998 Photodiode 
Array Detector.
For HPLC, an improved version of a recently published 
method (Csupor et al., 2009) has been applied. In brief, 
1 g roughly powdered drug was ground, passed through a 
0.315 mm sieve, extracted with 5 mL of 1% HCl solution for 
20 min at room temperature in an ultrasonic bath. After 
centrifugation (10 min at 4500 rpm), the filtered (0.45 μm 
filter membrane) supernatant was analyzed by HPLC (col-
umn: Phenomenex Gemini 5 µm, 0.1 m × 4.6 mm; mobile 
phase: A: 10 mM aqueous NH
4
HCO
3
 buffer pH 10 ± 0.2 
with 28% ammonia solution, B: acetonitrile; 0 min: 70% 
A, 4 min: 60% A, 20 min: 55% A, 30 min: 20% A, 35 min: 
70% A; flow rate: 1.1 mL/min, detection: 233 nm, injected 
sample volume: 20 μL). Peaks of mesaconitine, aconitine, 
and hypaconitine were identified by comparison of the 
HPLC-DAD chromatograms of the extracts of aconite 
roots with the HPLC-DAD chromatograms of reference 
solutions. Alkaloid content was calculated by comparison 
of the sum of the areas under curves (AUC) of mesaconi-
tine, aconitine, and hypaconitine on the basis of the cali-
bration curve established for aconitine. Calibration was 
established for aconitine based on five concentrations 
(with a range of 0.05–1.625 μg).
Alkaloid titration was carried out according the 
method of the German Homeopathic Pharmacopoeia 
(2005). To 2 g of the powdered drug, 8 mL of 1% HCl solu-
tion was added and extracted for 20 min at room tem-
perature in an ultrasonic bath. After centrifugation, the 
supernatant was filtered and washed with 1 mL of 1% HCl 
solution. Diluted ammonia was added to the filtrate until 
the mixture became alkaline. CHCl
3
 (60 g) was added 
to the extract and shaken for 15 min, then 2 g of freshly 
powdered tragacanth was added, shaken again, and fil-
tered into a dry flask. The filtrate was concentrated to a 
few milliliters; 10 mL of 0.01 M HCl and 5 mL of H
2
O were 
added; and the remainder of the CHCl
3
 was evaporated. 
This solution was titrated with 0.01 M NaOH using methyl 
red as indicator.
To assess the relation of alkaloid content and toxicity, 
after the quantitative analysis five samples were selected 
for in vivo toxicological investigation. The extracts of 
these drugs were dissolved in physiological saline con-
taining 5% dimethyl sulfoxide and intraperitoneally 
Table 1. Origin of investigated aconite roots.
Code Simplified code for HPLC analyses
Zhicaowu—Aconiti kusnezoffi praeparata
37951 B3 (EDQM)
37747 B4 (EDQM)
— B6 (Hong Kong Baptist University)
Zhichuanwu (Shanxi)—Aconiti praeparata (radix)
32969 D1 (EDQM)
— D2 (Hong Kong Baptist University)
Aconiti carmichaeli radix praeparata/Aconiti radix praeparata
28479 E1 (EDQM)
36890 E2 (EDQM)
Shanghai market—Aconiti radix praeparata/Aconiti radix 
lateralis praeparata
37271 F2—2003
37270 F3—2004
37269 F4—2005
37275 F5—2008
37272 F6—2009
German market—Aconiti radix praeparata/Aconiti radix lateralis 
praeparata
37276 G1—2004
37265 G2—2004
37263 G4—2007
37266 G5—2007
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administered to male CFLP mice (24–30 g). Two of 
the tested extracts (E2, F5) were administered at three 
doses (equivalent to 240, 800, and 2400 mg of drug/
kg), whereas the others (B3, D, G2) were given only at 
the highest dose for 5–5 animals. Mice were observed 
5 min, 2 h, and 6 h after administration as well as once 
a day for five additional days. The experimental proto-
col satisfied the Guidelines for Animal Experimentation 
approved by the Animal Experimentation Committee of 
the University of Szeged.
Results and discussion
The developed HPLC method provides good separation 
of the main toxic alkaloids (Figure 3) and therefore serves 
as basis for reliable quantitative analysis. For quantitative 
determination, linear regression analysis for aconitine was 
performed by the external standard method. The regres-
sion equation for aconitine was y = 2 999 256 695.1674x + 
66 930.4245 (x stands for the amount of injected alkaloid 
in mg, y denotes the area under the curve). The correla-
tion coefficient (R2) was 0.9994. Using the HPLC method, 
in most of the samples no toxic alkaloids or only traces 
could be detected (Table 2). However, in four samples 
(D1, E2, F5, G4), >0.04% of aconitine, hypaconitine, and 
mesaconitine, the highest with a content of 0.162% (E2), 
were quantified. The alkaloid content of these samples is 
high enough to question their safety.
The alkaloid content determined by titration was con-
siderably higher than determined by HPLC. Samples, in 
which toxic alkaloids were not detectable by HPLC, still 
contained up to 0.2% alkaloids according to titration. 
Careful processing obviously degrades the toxic alkaloids 
but does not remove all alkaloids. Total alkaloid titration 
determines not only the toxic diester alkaloids but also 
the monoester, unesterified, and lipo-alkaloids. There was 
no correlation between the low values (<0.02% HPLC), 
but there was a correlation in high values of alkaloid con-
tents determined by the two methods (Figure 4). When 
taking into consideration only samples with measurable 
alkaloid content by HPLC, a correlation coefficient of 0.91 
was found between the results of the two methods.
Acute toxicity of batches (E2, F5) high in diterpene 
alkaloids has been confirmed in CFLP mice. Extract of E2 
proved to be the most toxic batch resulting in death of two 
out of five mice at the highest dose. These fatal cases were 
preceded by intensive skeletal muscle cramps and short-
ness of breath. Similar excitatory skeletal symptoms were 
characteristic for all groups except for G2. An intensive 
defecation was observed on mice treated with extracts 
E2 and F5. The next day and later on, all surviving ani-
mals were in good condition exhibiting no obvious toxic 
symptoms.
Although the pharmacological characteristics of 
Aconitum diterpene alkaloids have been extensively 
studied (Ameri, 1998), the exact mode of action of tradi-
tionally applied aconite drugs has not been elucidated so 
Figure 3. HPLC chromatogram of the extract prepared from a crude aconite root sample.
Table 2. Content of alkaloids determined by titration and by 
HPLC analysis of toxic alkaloids (sum of mesaconitine, aconitine, 
and hypaconitine).
Code HPLC (%) Titration (%)
Radix aconiti kusnezoffii praeparata
B3 Not detectable 0.065
B4 0.007 0.013
B6 Not detectable 0.194
Radix aconiti carmichaeli praeparata/Radix aconiti lateralis 
praeparata
D1 0.054 0.207
D2 Not detectable 0.120
E1 0.013 0.062
E2 0.162 0.433
F2 Not detectable 0.045
F3 Not detectable 0.103
F4 Not detectable 0.123
F5 0.125 0.342
F6 Not detectable 0.070
G1 0.003 0.113
G2 0.026 0.129
G4 0.043 0.097
G5 0.011 0.116
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far; therefore, it is not possible to standardize these plant 
materials to any active agent.
Conclusions
Alkaloid titration, a method applied in the quality con-
trol of homeopathic aconite tinctures and aconite drugs 
of the Chinese Pharmacopoeia, may give information on 
total content of alkaloids, but allows no conclusion on 
the content of toxic alkaloids. Therefore, quantification 
of diester-type diterpene alkaloids is essential to ensure 
the safety of medicines based on these herbal drugs.
The sample preparation and HPLC analysis method 
developed by us offers a quick and reliable possibility 
to determine the quantity of the most important toxic 
alkaloids of A. carmichaeli and A. kusnezoffii and should 
now be considered as a purity test in pharmacopoeias. 
The relevance of our method was confirmed in in vivo 
toxicity studies, which exhibited an apparent correlation 
between the alkaloid content and the severity of toxic 
symptoms.
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